Anthera Pharmaceuticals Inc (NASDAQ:ANTH)

4.74
Delayed Data
As of May 22
 -0.01 / -0.21%
Today’s Change
1.46
Today|||52-Week Range
6.37
+200.00%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-95.3M-59.4M-30.9M-29.6M
 
 
 
 
 
Depreciation80.0K331.0K353.0K344.0K
 
 
 
 
 
Total Other Cash Flow3.2M1.9M4.3M3.6M
 
 
 
 
 
Funds From Operations-92.0M-57.2M-26.2M-25.6M
 
 
 
 
 
Funds From/For Other Operating Expenses-19.0M16.4M5.7M-39.0K
 
 
 
 
 
Net Cash Flow - Operating Activities-73.1M-73.6M-31.9M-25.6M
 
 
 
 
 
 
InvestingIncrease In Investments-4.7M-10.7M0.000.00
 
 
 
Decrease In Investments26.3M7.1M5.3M0.00
 
 
 
 
Capital Expenditures-1.3M-207.0K-15.0K0.00
 
 
 
 
Other Investing - Uses0.000.00-10.0M0.00
 
 
Other Investing - Sources0.000.000.0010.0M
 
 
Net Cash Flow Investing20.2M-3.8M-4.7M10.0M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings24.7M0.0019.8M0.00
 
 
 
Long Term Debt Reduction0.00-4.5M-22.4M-18.1M
 
 
 
 
Net Proceeds Stock Sale54.6M35.8M45.8M10.4M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing879.0K37.0K32.0K0.00
 
 
 
 
Net Cash Flow - Financing78.4M31.3M43.1M-7.7M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash---31.0K-1.0K0.00
 
 
 
 
Net Change In Cash25.6M-46.2M6.5M-23.3M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account